Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Do Hedge Funds Think of Accelerate Diagnostics Inc (AXDX)?

Page 1 of 2

Between June 25 and October 30th the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 14 percentage points as investors worried over the possible ramifications of rising interest rates. The hedge funds and institutional investors we track typically invest more in smaller-cap stocks than an average investor, and we have seen data that shows those funds paring back their overall exposure. Those funds cutting positions in small-caps is one reason why volatility has increased. In the following paragraphs, we take a closer look at what hedge funds and prominent investors think of Accelerate Diagnostics Inc (NASDAQ:AXDX) and see how the stock is affected by the recent hedge fund activity.

Accelerate Diagnostics Inc (NASDAQ:AXDX) was in 11 hedge funds’ portfolios at the end of September. AXDX shareholders have witnessed a decrease in support from the world’s most elite money managers of late. There were 14 hedge funds in our database with AXDX holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as National Bank Holdings Corp (NYSE:NBHC), Kronos Worldwide, Inc. (NYSE:KRO), and Employers Holdings, Inc. (NYSE:EIG) to gather more data points.

If you’d ask most traders, hedge funds are assumed to be slow, old investment vehicles of years past. While there are more than 8,000 funds in operation at present, We hone in on the masters of this group, approximately 700 funds. These money managers command most of the hedge fund industry’s total capital, and by following their top equity investments, Insider Monkey has uncovered many investment strategies that have historically exceeded the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy surpassed the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, let’s analyze the latest action surrounding Accelerate Diagnostics Inc (NASDAQ:AXDX).

What does the smart money think about Accelerate Diagnostics Inc (NASDAQ:AXDX)?

At Q3’s end, a total of 11 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -21% from the second quarter. With hedgies’ sentiment swirling, there exists a select group of key hedge fund managers who were boosting their holdings substantially (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Matthew Strobeck’s Birchview Capital has the largest position in Accelerate Diagnostics Inc (NASDAQ:AXDX), worth close to $33.5 million, comprising 20% of its total 13F portfolio. On Birchview Capital’s heels is Miura Global Management, managed by Pasco Alfaro / Richard Tumure, which holds a $9.7 million position; 0.5% of its 13F portfolio is allocated to the stock. Other members of the smart money that hold long positions contain Stewart Strawbridge’s Selkirk Management, Stuart Weisbrod’s Iguana Healthcare Management and Israel Englander’s Millennium Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!